HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Bailly Selected Research

Type II DNA Topoisomerases (Topoisomerase II)

2/2014The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
6/2007Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
10/2001DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivatives.
8/2001Novel dications with unfused aromatic systems: trithiophene and trifuran derivatives of furimidazoline.
1/2001DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells.
8/2000Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells.
7/2000Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.
6/2000DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Bailly Research Topics

Disease

21Neoplasms (Cancer)
02/2014 - 01/2000
13Leukemia
10/2010 - 02/2000
8Carcinoma (Carcinomatosis)
12/2009 - 01/2001
4Poisoning
02/2014 - 06/2000
3Leukemia P388
09/2001 - 08/2000
2Neoplasm Metastasis (Metastasis)
01/2021 - 07/2004
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2001
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2008 - 10/2004
2Breast Neoplasms (Breast Cancer)
11/2003 - 09/2000
2Opportunistic Infections (Opportunistic Infection)
07/2002 - 10/2000
1Prostatic Neoplasms (Prostate Cancer)
11/2015
1Hepatitis A (Hepatitis, Infectious)
09/2015
1Chickenpox
09/2015
1Chronic Disease (Chronic Diseases)
09/2015
1Hepatitis B
09/2015
1Squamous Cell Carcinoma of Head and Neck
02/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2014
1Hypoxia (Hypoxemia)
02/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2013
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2011
1Adenocarcinoma
12/2006
1Leiomyoma (Uterine Fibroids)
12/2006
1Uterine Hemorrhage (Uterine Bleeding)
12/2006
1Leishmaniasis
08/2004
1Chagas Disease (American Trypanosomiasis)
08/2004
1Parasitic Diseases (Parasitic Disease)
08/2004
1Neuroblastoma
07/2004
1Glioma (Gliomas)
04/2003
1Hematologic Neoplasms (Hematological Malignancy)
07/2002
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2002
1Drug-Related Side Effects and Adverse Reactions
07/2001
1Endometrial Neoplasms (Endometrial Cancer)
04/2001
1Microsatellite Instability
01/2001
1Leukemia L1210
12/2000

Drug/Important Bio-Agent (IBA)

14DNA (Deoxyribonucleic Acid)IBA
06/2007 - 03/2000
9Pharmaceutical PreparationsIBA
02/2014 - 04/2000
8Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2014 - 06/2000
7CamptothecinIBA
09/2001 - 01/2000
7Type I DNA Topoisomerases (Topoisomerase I)IBA
09/2001 - 04/2000
4Antineoplastic Agents (Antineoplastics)IBA
02/2014 - 08/2000
4Proteins (Proteins, Gene)FDA Link
06/2007 - 06/2000
4Irinotecan (Camptosar)FDA LinkGeneric
09/2001 - 01/2000
3Etoposide (VP 16)FDA LinkGeneric
02/2014 - 07/2000
3PolyaminesIBA
02/2014 - 10/2010
3F14512IBA
02/2014 - 10/2010
3Mitoxantrone (Novantrone)FDA LinkGeneric
10/2001 - 08/2000
3NB 506IBA
09/2001 - 01/2001
3PoisonsIBA
08/2001 - 01/2001
2Monoclonal AntibodiesIBA
01/2021 - 09/2000
2SpermineIBA
02/2014 - 10/2010
2Podophyllotoxin (Condylox)FDA LinkGeneric
10/2010 - 07/2000
2Amsacrine (AMSA)IBA
06/2007 - 12/2000
2Indicators and Reagents (Reagents)IBA
10/2004 - 03/2000
2EnzymesIBA
10/2001 - 07/2001
2diflomotecanIBA
09/2001 - 01/2001
2rebeccamycinIBA
07/2001 - 02/2000
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2001 - 04/2000
2cryptolepineIBA
12/2000 - 06/2000
2AlkaloidsIBA
08/2000 - 06/2000
1Carcinoembryonic AntigenIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
01/2021
1fluorocholineIBA
11/2015
1VaccinesIBA
09/2015
1Cisplatin (Platino)FDA LinkGeneric
02/2014
1F 96982IBA
10/2010
1AcridinesIBA
06/2007
1CarbazolesIBA
03/2005
1antigen CYFRA21.1IBA
10/2004
1furamidine (DB75)IBA
08/2004
13-Iodobenzylguanidine (Iobenguane)IBA
07/2004
1ABA833IBA
11/2003
1ABA13IBA
11/2003
1BenzimidazolesIBA
11/2003
1Carmustine (FIVB)FDA Link
04/2003
1homocamptothecinIBA
09/2001
1DB358IBA
08/2001
1ImidazolinesIBA
08/2001
1Anti-Bacterial Agents (Antibiotics)IBA
07/2001
1OligonucleotidesIBA
07/2001
1A-Form DNA (A-DNA)IBA
07/2001
1Intercalating AgentsIBA
02/2001
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2001
1Karwinskia toxin T-514IBA
01/2001
1Calcibiotic Root Canal SealerIBA
01/2001
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2001
1neocryptolepineIBA
12/2000
1CationsIBA
10/2000

Therapy/Procedure

7Drug Therapy (Chemotherapy)
02/2014 - 07/2001
3Radiotherapy
02/2014 - 04/2001
2Hysterectomy
12/2006 - 02/2001
2Induction Chemotherapy
10/2004 - 07/2004
2Hematopoietic Stem Cell Transplantation
04/2003 - 07/2002
1Therapeutics
02/2014
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2011
1Neoadjuvant Therapy
12/2009
1Ovariectomy (Oophorectomy)
12/2006
1Transplantation
04/2003
1Homologous Transplantation
07/2002
1Salpingo-oophorectomy
02/2001